货号:A477540
同义名:
GNF-Pf-1127; CID 3238952
ML348 is a selective and reversible lysophospholipase 1 (LYPLA1) inhibitor (IC50 = 210 nM), Exhibits 14-fold selectivity for LYPLA1 over LYPLA2, Also selective over a panel of ~30 other serine hydrolases.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | ML348, also known as GNF-Pf-1127, acts as a potent and specific inhibitor of acyl-protein thioesterase 1 (APT1)/lysophospholipase 1 (LYPLA1), exhibiting an IC50 value of 210 nM. It demonstrates minimal inhibitory effects on LYPLA2. When applied to cultured cells at a concentration of 5 μM for a duration of 3 hours, ML348 effectively and selectively targets LYPLA1. This has been observed in cell lines such as HEK293T cells and murine T-cells, where the compound shows significant inhibition of LYPLA1 activity[1]. |
作用机制 | ML348 inhibits LYPLA1 by occupying a putative acyl-binding region, establishing the mechanism for isoform-specific inhibition and hydrolysis of acyl substrates. |
Dose | Mice: 50 mg/kg[1] (i.p.) |
Administration | i.p. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.40mL 0.48mL 0.24mL |
12.03mL 2.40mL 1.20mL |
24.05mL 4.81mL 2.40mL |
CAS号 | 899713-86-1 |
分子式 | C18H17ClF3N3O3 |
分子量 | 415.79 |
SMILES Code | O=C(NC1=CC(C(F)(F)F)=CC=C1Cl)CN2CCN(C(C3=CC=CO3)=O)CC2 |
MDL No. | N/A |
别名 | GNF-Pf-1127; CID 3238952; SID 160654487 |
运输 | 蓝冰 |
InChI Key | OXKNHBBDOIMFFQ-UHFFFAOYSA-N |
Pubchem ID | 3238952 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Sealed in dry, 2-8°C |
溶解方案 |
请根据您的动物给药指南选择适当的溶解方案。 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|